A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

Background/Purpose: Stereotactic ablative radiotherapy (SABR) is the treatment of choice for medically inoperable, early-stage non-small cell lung cancer (ES-NSCLC). The influence of oncogenic driver alterations and comorbidities are not well known. Here we present treatment outcomes based on clinic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: I-Han Lee, Guann-Yiing Chen, Chun-Ru Chien, Jason Chia-Hsien Cheng, Jenny Ling-Yu Chen, Wen-Chi Yang, Jin-Shing Chen, Feng-Ming Hsu
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Stereotactic ablative radiotherapy
Non-small cell lung cancer
Prognostic factor
Oncogenic driver alteration
Inoperable early-stage
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/8f093c41272a4b83bdc71725bb97894e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares